The Journal of Nutritional Biochemistry
Volume 18, Issue 12 , Pages 806-812 , December 2007

COX-2 expression in cystic kidneys is dependent on dietary n-3 fatty acid composition

  • Deepa Sankaran

      Affiliations

    • Department of Human Nutritional Sciences, University of Manitoba, Winnipeg, Manitoba, Canada R3T 2N2
  • ,
  • Jing Lu

      Affiliations

    • Department of Nutrition and Food Sciences, Texas Woman's University, Denton, TX 76204-5888, USA
    • Present Address: Department of Pediatrics, Northwestern University Feinberg School of Medicine, Evanston Northwestern Healthcare, Evanston, IL, USA.
  • ,
  • Malcolm R. Ogborn

      Affiliations

    • Department of Human Nutritional Sciences, University of Manitoba, Winnipeg, Manitoba, Canada R3T 2N2
    • Manitoba Institute of Child Health, Winnipeg, Manitoba, Canada R3E 3P4
  • ,
  • Harold M. Aukema

      Affiliations

    • Department of Human Nutritional Sciences, University of Manitoba, Winnipeg, Manitoba, Canada R3T 2N2
    • Manitoba Institute of Child Health, Winnipeg, Manitoba, Canada R3E 3P4
    • Corresponding Author InformationCorresponding author. Department of Human Nutritional Sciences, University of Manitoba, Winnipeg, Manitoba, Canada R3T 2N2. Tel.: +1 204 474 8076; fax: +1 204 474 7593.

Received 16 June 2006 ,Revised 27 November 2006 ,Accepted 6 December 2006.

References 

  1. Vane JR, Bakhle YS, Botting RM. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol. 1998;38:97–120
  2. Breyer MD, Harris RC. Cyclooxygenase 2 and the kidney. Curr Opin Nephrol Hypertens. 2001;10:89–98
  3. Yang P, Chan D, Felix E, Cartwright C, Menter DG, Madden T, et al. Formation and antiproliferative effect of prostaglandin E(3) from eicosapentaenoic acid in human lung cancer cells. J Lipid Res. 2004;45:1030–1039
  4. Calviello G, Di Nicuolo F, Gragnoli S, Piccioni E, Serini S, Maggiano N, et al. n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway. Carcinogenesis. 2004;25:2303–2310
  5. Vecchini A, Ceccarelli V, Susta F, Caligiana P, Orvietani P, Binaglia L, et al. Dietary alpha-linolenic acid reduces COX-2 expression and induces apoptosis of hepatoma cells. J Lipid Res. 2004;45:308–316
  6. Rao CV, Hirose Y, Indranie C, Reddy BS. Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids. Cancer Res. 2001;61:1927–1933
  7. Denkins Y, Kempf D, Ferniz M, Nileshwar S, Marchetti D. Role of omega-3 polyunsaturated fatty acids on cyclooxygenase-2 metabolism in brain-metastatic melanoma. J Lipid Res. 2005;46:1278–1284
  8. Horia E, Watkins BA. Comparison of stearidonic acid and alpha-linolenic acid on PGE2 production and COX-2 protein levels in MDA-MB-231 breast cancer cell cultures. J Nutr Biochem. 2005;16:184–192
  9. Dommels YE, Haring MM, Keestra NG, Alink GM, van Bladeren PJ, van Ommen B. The role of cyclooxygenase in n-6 and n-3 polyunsaturated fatty acid mediated effects on cell proliferation, PGE(2) synthesis and cytotoxicity in human colorectal carcinoma cell lines. Carcinogenesis. 2003;24:385–392
  10. Jia Q, Zhou HR, Bennink M, Pestka JJ. Docosahexaenoic acid attenuates mycotoxin-induced immunoglobulin a nephropathy, interleukin-6 transcription, and mitogen-activated protein kinase phosphorylation in mice. J Nutr. 2004;134:3343–3349
  11. Moon Y, Pestka JJ. Deoxynivalenol-induced mitogen-activated protein kinase phosphorylation and IL-6 expression in mice suppressed by fish oil. J Nutr Biochem. 2003;14:717–726
  12. Du C, Fujii Y, Ito M, Harada M, Moriyama E, Shimada R, et al. Dietary polyunsaturated fatty acids suppress acute hepatitis, alter gene expression and prolong survival of female Long-Evans Cinnamon rats, a model of Wilson disease. J Nutr Biochem. 2004;15:273–280
  13. Aukema HM, Adolphe J, Mishra S, Jiang J, Cuozzo FP, Ogborn MR. Alterations in renal cytosolic phospholipase A2 and cyclooxygenases in polycystic kidney disease. FASEB J. 2003;17:298–300
  14. Warford-Woolgar L, Peng CY, Shuhyta J, Wakefield A, Sankaran D, Ogborn M, et al. Selectivity of cyclooxygenase (COX) isoform activity and prostanoid production in normal and diseased Han:SPRD-cy rat kidneys. Am J Physiol Renal Physiol. 2006;290:897–904
  15. Iglesias CG, Torres VE, Offord KP, Holley KE, Beard CM, Kurland LT. Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935–1980. Am J Kidney Dis. 1983;2:630–639
  16. Takahashi H, Calvet JP, Dittemore-Hoover D, Yoshida K, Grantham JJ, Gattone VH. A hereditary model of slowly progressive polycystic kidney disease in the mouse. J Am Soc Nephrol. 1991;1:980–989
  17. Sankaran D, Lu J, Bankovic-Calic N, Ogborn MR, Aukema HM. Modulation of renal injury in pcy mice by dietary fat containing n-3 fatty acids depends on the level and type of fat. Lipids. 2004;39:207–214
  18. Cowley BD, Gudapaty S, Kraybill AL, Barash BD, Harding MA, Calvet JP, et al. Autosomal-dominant polycystic kidney disease in the rat. Kidney Int. 1993;43:522–534
  19. Lu J, Bankovic-Calic N, Ogborn M, Saboorian MH, Aukema HM. Detrimental effects of a high fat diet in early renal injury are ameliorated by fish oil in Han:SPRD-cy rats. J Nutr. 2003;133:180–186
  20. Ogborn MR, Nitschmann E, Bankovic-Calic N, Weiler HA, Aukema H. Dietary flax oil reduces renal injury, oxidized LDL content, and tissue n-6/n-3 FA ratio in experimental polycystic kidney disease. Lipids. 2002;37:1059–1065
  21. Singh J, Hamid R, Reddy BS. Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis. Cancer Res. 1997;57:3465–3470
  22. Lee JY, Plakidas A, Lee WH, Heikkinen A, Chanmugam P, Bray G, et al. Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids. J Lipid Res. 2003;44:479–486
  23. Lo CJ, Chiu KC, Fu M, Lo R, Helton S. Fish oil augments macrophage cyclooxygenase II (COX-2) gene expression induced by endotoxin. J Surg Res. 1999;86:103–107
  24. Aukema HM, Yamaguchi T, Takahashi H, Philbrick DJ, Holub BJ. Effects of dietary fish oil on survival and renal fatty acid composition in murine polycystic kidney disease. Nutr Res. 1992;12:1383–1392
  25. Gorgoni B, Caivano M, Arizmendi C, Poli V. The transcription factor C/EBPbeta is essential for inducible expression of the cox-2 gene in macrophages but not in fibroblasts. J Biol Chem. 2001;276:40769–40777
  26. Tak PP, Firestein GS. NF-kappaB: a key role in inflammatory diseases. J Clin Invest. 2001;107:7–11
  27. Sheu ML, Chao KF, Sung YJ, Lin WW, Lin-Shiau SY, Liu SH. Activation of phosphoinositide 3-kinase in response to inflammation and nitric oxide leads to the up-regulation of cyclooxygenase-2 expression and subsequent cell proliferation in mesangial cells. Cell Signal. 2005;17:975–984
  28. Bousserouel S, Brouillet A, Bereziat G, Raymondjean M, Andreani M. Different effects of n-6 and n-3 polyunsaturated fatty acids on the activation of rat smooth muscle cells by interleukin-1 beta. J Lipid Res. 2003;44:601–611
  29. Calder PC. Dietary modification of inflammation with lipids. Proc Nutr Soc. 2002;61:345–358
  30. Babcock TA, Helton WS, Anwar KN, Zhao YY, Espat NJ. Synergistic anti-inflammatory activity of omega-3 lipid and rofecoxib pretreatment on macrophage proinflammatory cytokine production occurs via divergent NF-kappaB activation. JPEN J Parenter Enteral Nutr. 2004;28:232–239[discussion 9-40]
  31. Laneuville O, Breuer DK, Xu N, Huang ZH, Gage DA, Watson JT, et al. Fatty acid substrate specificities of human prostaglandin-endoperoxide H synthase-1 and -2. Formation of 12-hydroxy-(9Z, 13E/Z, 15Z)-octadecatrienoic acids from alpha-linolenic acid. J Biol Chem. 1995;270:19330–19336
  32. Horiba N, Kumano E, Watanabe T, Shinkura H, Sugimoto T, Inoue M. Subtotal nephrectomy stimulates cyclooxygenase 2 expression and prostacyclin synthesis in the rat remnant kidney. Nephron. 2002;91:134–141
  33. Hirose S, Yamamoto T, Feng L, Yaoita E, Kawasaki K, Goto S, et al. Expression and localization of cyclooxygenase isoforms and cytosolic phospholipase A2 in anti-Thy-1 glomerulonephritis. J Am Soc Nephrol. 1998;9:408–416
  34. Komers R, Lindsley JN, Oyama TT, Schutzer WE, Reed JF, Mader SL, et al. Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes. J Clin Invest. 2001;107:889–898
  35. Wang JL, Cheng HF, Harris RC. Cyclooxygenase-2 inhibition decreases renin content and lowers blood pressure in a model of renovascular hypertension. Hypertension. 1999;34:96–101
  36. Wang JL, Cheng HF, Shappell S, Harris RC. A selective cyclooxygenase-2 inhibitor decreases proteinuria and retards progressive renal injury in rats. Kidney Int. 2000;57:2334–2342
  37. Rao CV, Reddy BS. Modulating effect of amount and types of dietary fat on ornithine decarboxylase, tyrosine protein kinase and prostaglandins production during colon carcinogenesis in male F344 rats. Carcinogenesis. 1993;14:1327–1333
  38. Takahashi M, Fukutake M, Isoi T, Fukuda K, Sato H, Yazawa K, et al. Suppression of azoxymethane-induced rat colon carcinoma development by a fish oil component, docosahexaenoic acid (DHA). Carcinogenesis. 1997;18:1337–1342
  39. Fujihara CK, Antunes GR, Mattar AL, Andreoli N, Malheiros DM, Noronha IL, et al. Cyclooxygenase-2 (COX-2) inhibition limits abnormal COX-2 expression and progressive injury in the remnant kidney. Kidney Int. 2003;64:2172–2181
  40. Al-Nimri MA, Komers R, Oyama TT, Subramanya AR, Lindsley JN, Anderson S. Endothelial-derived vasoactive mediators in polycystic kidney disease. Kidney Int. 2003;63:1776–1784

 This work was supported by grants from National Science and Engineering Research Council, Canada; Manitoba Institute of Child Health, Manitoba, Canada (a division of the Children's Hospital Foundation of Manitoba, Inc.); Texas Foods and Fibers Commission; and a Manitoba Health Research Council Graduate Fellowship (DS).

PII: S0955-2863(07)00027-7

doi: 10.1016/j.jnutbio.2006.12.017

The Journal of Nutritional Biochemistry
Volume 18, Issue 12 , Pages 806-812 , December 2007